176 related articles for article (PubMed ID: 19376452)
1. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
Haritoglou C; Gerss J; Sauerland C; Kampik A; Ulbig MW;
Lancet; 2009 Apr; 373(9672):1364-71. PubMed ID: 19376452
[TBL] [Abstract][Full Text] [Related]
2. Prevention of diabetic retinopathy.
Einarsdóttir AB; Stefánsson E
Lancet; 2009 Apr; 373(9672):1316-8. PubMed ID: 19376433
[No Abstract] [Full Text] [Related]
3. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
Ribeiro ML; Seres AI; Carneiro AM; Stur M; Zourdani A; Caillon P; Cunha-Vaz JG;
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1591-600. PubMed ID: 16763797
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind multicentre clinical trial comparing the efficacy of calcium dobesilate with placebo in the treatment of chronic venous disease.
Martínez-Zapata MJ; Moreno RM; Gich I; Urrútia G; Bonfill X;
Eur J Vasc Endovasc Surg; 2008 Mar; 35(3):358-65. PubMed ID: 17962050
[TBL] [Abstract][Full Text] [Related]
5. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.
Keech AC; Mitchell P; Summanen PA; O'Day J; Davis TM; Moffitt MS; Taskinen MR; Simes RJ; Tse D; Williamson E; Merrifield A; Laatikainen LT; d'Emden MC; Crimet DC; O'Connell RL; Colman PG;
Lancet; 2007 Nov; 370(9600):1687-97. PubMed ID: 17988728
[TBL] [Abstract][Full Text] [Related]
6. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.
Sjølie AK; Klein R; Porta M; Orchard T; Fuller J; Parving HH; Bilous R; Chaturvedi N;
Lancet; 2008 Oct; 372(9647):1385-93. PubMed ID: 18823658
[TBL] [Abstract][Full Text] [Related]
7. The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.
Stamper RL; Smith ME; Aronson SB; Cavender JC; Cleasby GW; Fung WE; Becker B
Ophthalmology; 1978 Jun; 85(6):594-606. PubMed ID: 353623
[TBL] [Abstract][Full Text] [Related]
8. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema.
Krepler K; Biowski R; Schrey S; Jandrasits K; Wedrich A
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):735-8. PubMed ID: 12271370
[TBL] [Abstract][Full Text] [Related]
9. Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy.
Berthet P; Farine JC; Barras JP
Int J Clin Pract; 1999 Dec; 53(8):631-6. PubMed ID: 10692760
[TBL] [Abstract][Full Text] [Related]
10. Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy.
Leite EB; Mota MC; de Abreu JR; Cunha-Vaz JG
Int Ophthalmol; 1990 Mar; 14(2):81-8. PubMed ID: 2187006
[TBL] [Abstract][Full Text] [Related]
11. The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial.
Larsen HW; Sander E; Hoppe R
Diabetologia; 1977 Apr; 13(2):105-9. PubMed ID: 323093
[TBL] [Abstract][Full Text] [Related]
12. Calcium dobesilate in diabetic retinopathy. A retrospective controlled study.
Adank C; Koerner F
Ophthalmologica; 1985; 190(2):102-11. PubMed ID: 3982791
[TBL] [Abstract][Full Text] [Related]
13. Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy.
Benarroch IS; Brodsky M; Rubinstein A; Viggiano C; Salama EA
Ophthalmic Res; 1985; 17(3):131-8. PubMed ID: 4011126
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease.
Flota-Cervera F; Flota-Ruiz C; Treviño C; Berber A
Angiology; 2008; 59(3):352-6. PubMed ID: 18388097
[TBL] [Abstract][Full Text] [Related]
15. [Effect of calcium dobesilate on progression of diabetic retinopathy].
Haas A; Trummer G; Eckhardt M; Schmut O; Uyguner I; Pfeiffer KP
Klin Monbl Augenheilkd; 1995 Jul; 207(1):17-21. PubMed ID: 7564132
[TBL] [Abstract][Full Text] [Related]
16. Calcium dobesilate in patients suffering from chronic venous insufficiency: a double-blind, placebo-controlled, clinical trial.
Rabe E; Jaeger KA; Bulitta M; Pannier F
Phlebology; 2011 Jun; 26(4):162-8. PubMed ID: 21478142
[TBL] [Abstract][Full Text] [Related]
17. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.
Chaturvedi N; Porta M; Klein R; Orchard T; Fuller J; Parving HH; Bilous R; Sjølie AK;
Lancet; 2008 Oct; 372(9647):1394-402. PubMed ID: 18823656
[TBL] [Abstract][Full Text] [Related]
18. Calcium dobesilate versus placebo in the treatment of diabetic retinopathy: a double-blind cross-over study.
Binkhorst PG; Van Bijsterveld OP
Curr Ther Res Clin Exp; 1976 Sep; 20(3):283-8. PubMed ID: 822986
[No Abstract] [Full Text] [Related]
19. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
Rota R; Chiavaroli C; Garay RP; Hannaert P
Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
[TBL] [Abstract][Full Text] [Related]
20. [The plasma levels of endothelin in diabetic retinopathy and their changes after treatment with doxium].
Zhong H; Guo L
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):56-8. PubMed ID: 9868029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
